Litigators of the Week: A Defense Verdict in Cook County in the First Zantac Trial
Defense lawyers for GSK, led by Tarek Ismail of Goldman Ismail, and Boehringer Ingelheim, led by Andrew Bayman of King & Spalding, won a defense verdict from state court jurors who rejected a claim that the discontinued heartburn drug Zantac caused an Illinois woman's colon cancer.
May 31, 2024 at 07:30 AM
7 minute read
Our Litigators of the Week, Tarek Ismail of Goldman Ismail Tomaselli Brennan & Baum and Andrew Bayman of King & Spalding, led teams representing GlaxoSmithKline and Boehringer Ingelheim respectively in the first trial considering claims that the discontinued heartburn drug Zantac causes cancer. Last week, after three weeks of trial and four hours of deliberations, a jury in Cook County Circuit Court rejected an Illinois woman's claim that the drug caused her colon cancer.
NOT FOR REPRINT
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
Law Firms Mentioned
Trending Stories
- 1The Law Firm Disrupted: For Big Law Names, Shorter is Sweeter
- 2Wine, Dine and Grind (Through the Weekend): Summer Associates Thirst For Experience in 'Real Matters'
- 3'That's Disappointing': Only 11% of MDL Appointments Went to Attorneys of Color in 2023
- 4What We Know About the Kentucky Judge Killed in His Chambers
- 5'I'm Staying Everything': Texas Bankruptcy Judge Halts Talc Trials Against J&J
Featured Firms
Law Offices of Gary Martin Hays & Associates, P.C.
(470) 294-1674
Law Offices of Mark E. Salomone
(857) 444-6468
Smith & Hassler
(713) 739-1250